Last updated: April 10, 2024
Sponsor: Jiangjiang Bi
Overall Status: Active - Recruiting
Phase
N/A
Condition
Gastric Cancer
Digestive System Neoplasms
Stomach Cancer
Treatment
probiotics
Clinical Study ID
NCT06186089
JJBi 2023
Ages 40-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Clinical diagnosis of proximal gastric cancer and will be performed gastrectomy
- American Society of Anesthesiologists (ASA) classification I-III
- Aged 40-80 years
- Perioperative consciousness
Exclusion
Exclusion Criteria:
- Central nervous system and psychological disorders
- Chronic use of sedatives, antidepressants within the last year
- Parkinson's disease
- Severe immunosuppression
- Severe hearing or vision impairment
- Drug dependence; alcoholism
- Inability to communicate with a physician
Study Design
Total Participants: 45
Treatment Group(s): 1
Primary Treatment: probiotics
Phase:
Study Start date:
January 20, 2024
Estimated Completion Date:
June 30, 2026
Study Description
Connect with a study center
Tongji Hospital
Wuhan, Hubei 430030
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.